Itau Unibanco Holding S.A.’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,060
Closed -$55.6K 375
2025
Q4
$55.6K Buy
1,060
+168
+19% +$10.1K ﹤0.01% 244
2025
Q3
$57.8K Hold
892
﹤0.01% 232
2025
Q2
$43.4K Sell
892
-12
-1% -$464 ﹤0.01% 271
2025
Q1
$31K Sell
904
-12
-1% -$509 ﹤0.01% 325
2024
Q4
$36.1K Buy
916
+157
+21% +$7.41K ﹤0.01% 308
2024
Q3
$35.7K Buy
759
+113
+17% +$5.73K ﹤0.01% 209
2024
Q2
$34.9K Buy
+646
New +$37.4K ﹤0.01% 192
2024
Q1
Sell
-1,498
Closed -$93.8K 177
2023
Q4
$93.8K Sell
1,498
-1,023
-41% -$56.6K ﹤0.01% 182
2023
Q3
$114K Buy
2,521
+245
+11% +$12.7K 0.01% 186
2023
Q2
$128K Buy
2,276
+675
+42% +$38.3K 0.01% 211
2023
Q1
$72.4K Sell
1,601
-80
-5% -$3.88K ﹤0.01% 307
2022
Q4
$67.8K Buy
1,681
+633
+60% +$33.6K ﹤0.01% 320
2022
Q3
$68K Sell
1,048
-361
-26% -$26.2K ﹤0.01% 364
2022
Q2
$86K Sell
1,409
-566
-29% -$33.3K ﹤0.01% 301
2022
Q1
$124K Buy
1,975
+21
+1% +$1.32K ﹤0.01% 264
2021
Q4
$154K Buy
1,954
+1,147
+142% +$100K ﹤0.01% 187
2021
Q3
$90K Buy
807
+180
+29% +$22.6K ﹤0.01% 196
2021
Q2
$102K Buy
+627
New +$76.3K 0.01% 139

Other funds holding CRSP